21–30 of 985 posts
Earlier quoted context omitted.
in europe there is a social stigma around GLP-1 drugs, a lot of people considered it cheating and lazy, so a lot of people don't dare talk about their usage
Or, you know, just less obese people
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024. I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US. In my friend circle in Germany I don't even know one single person on this stuff. It's insane to me that so many people need these to get off the processed foods killing them…
> It's insane to me that so many people need these to get off the processed foods killing them in the US.
Your comparison of your friends in Germany vs "insanity" in the US doesn't feel relevant
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024. I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US. In my friend circle in Germany I don't even know one single person on this stuff. It's insane to me that so many people need these to get off the processed foods killing them…
I do think this could only be temporary victory over the food industry by the pharmacology industry. It's only a matter of time until food additives or varieties are discovered that partially ameliorate the effects of ozempic.
... do you have any evidence to back up this claim?
> Spending on savory snacks dropped by about 10%, with similarly large decreases in sweets, baked goods and cookies. Even staples like bread, meat and eggs declined.
I can't read the paper (paywall), but that means something like the 10% of Americans who are on it must switch to purchasing almost no junk food.
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024. I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US. In my friend circle in Germany I don't even know one single person on this stuff. It's insane to me that so many people need these to get off the processed foods killing them…
in europe there is a social stigma around GLP-1 drugs, a lot of people considered it cheating and lazy, so a lot of people don't dare talk about their usage
Earlier quoted context omitted.
in europe there is a social stigma around GLP-1 drugs, a lot of people considered it cheating and lazy, so a lot of people don't dare talk about their usage
Or, you know, just less obese people
I do think this could only be temporary victory over the food industry by the pharmacology industry. It's only a matter of time until food additives or varieties are discovered that partially ameliorate the effects of ozempic.
... do you have any evidence to back up this claim?
Demanding evidence for predictions like this is a bit... hm. Arrogant, maybe. A prediction is a commitment. We want people to make predictions. The evidence we get when those predictions come true or not. Would you be willing to make the opposite prediction?